B.C. biotech company says, despite interim approval, provinces won't use its COVID-19 treatment

The CEO of a B.C. biotechnology company says the treatment his firm has developed for COVID-19 is sitting on shelves while people continue to die, despite it being approved for use by Health Canada in the fall.